ArticleOncology letters2022

Anlotinib inhibits the proliferation, migration and invasion, and induces apoptosis of breast cancer cells by downregulating TFAP2C.

Fuxiao Fang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.